FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
22/11/2025
Voltar para busca
Dado oficial do USPTO
JP
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
40, 42, 44
Data de depósito
13/12/2023
Data de registro
15/04/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/04/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
CH
Examinador
PEISECKI, MARK A
Unidade examinadora
L50
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the stylized letters "JP" within a circle comprised of smaller shaded circles.
Titulares e representantes
Titulares
Jetpharma SA
Representantes
Jason DeFrancesco DeFrancescoLaw
Classificação técnica
Classes Nice
Classe 40Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 40
Processing services for active pharmaceutical ingredients and pharmaceutical intermediatescustom manufacture of pharmaceuticals; custom manufacture of pharmaceutical products to order and in accordance with a customer's requirements; manufacturing of bio-pharmaceutical materials for others; treatment of bio-pharmaceutical materials by means of particle size engineering processings; microencapsulation services for third partieschemical encapsulation and dispersion of hazardous chemicals
Classe 42
Providing medical and scientific research information in the field of pharmaceutical products; pharmaceutical research and development; medicine discovery servicesnamely research and development of medicines; pharmaceutical research and development services; technical and scientific advice relating to pharmacology; technical and scientific advice relating to pharmaceutical research; research and development of pharmaceutical products and medicines; inspection of pharmaceutical products for quality control; technical and scientific laboratory research in the field of pharmaceutical products; research in the field of pharmaceutical products; scientific research in the pharmaceutical field; pharmacological research services; medical and pharmacological research services; services for assessing the efficiency of pharmaceutical productsnamely testing of pharmaceuticals; drug development for pharmaceutical use; development of pharmaceutical products; conducting preliminary evaluations in the field of new pharmaceutical productstesting of pharmaceuticals; testing of pharmaceutical products; evaluation of the quality of pharmaceutical products; quality evaluation of chemical syntheses in the field of pharmaceuticals; technical consultancy services in the field of pharmaceuticals products
Classe 44
Consultant services relating to pharmaceutical and medical productsmedical and pharmaceutical consultation; provision of information in the pharmaceutical field relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals; consultant and information services relating to biopharmaceutical productspharmaceutical consultations; consultant and information services relating to pharmaceutical productspharmaceutical consultation; consultancy services relating to pharmaceutical products; pharmaceutical advice; dispensing of pharmaceutical products
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
31/10/2025
FIMP
FINAL DISPOSITION PROCESSED
31/10/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
10/10/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
24/09/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
24/09/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
16/07/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
15/04/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
15/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25/02/2025
PUBO
PUBLISHED FOR OPPOSITION
25/02/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/02/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/01/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/01/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/01/2025
RFNT
REFUSAL PROCESSED BY IB
25/08/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/08/2024
RFRR
REFUSAL PROCESSED BY MPU
05/08/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
16/07/2024
CNRT
NON-FINAL ACTION WRITTEN
15/07/2024
DOCK
ASSIGNED TO EXAMINER
11/07/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
20/05/2024
MAFR
APPLICATION FILING RECEIPT MAILED
09/05/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/05/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
25/04/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace JP ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.